Nutex Health reports FY 2024 net income of $52.2M vs loss of $45.8M in 2023; revenue up 93.8% to $479.9M

Nutex Health Inc.

2025-Q1 EPS reported $2.56 revenue$211,789,000

FY 2024 total revenue $479.9M (+93.8% YoY); net income $52.2M vs net loss $45.8M in 2023.
Diluted EPS $9.71 vs $(10.39); Adjusted EBITDA $123.7M up 1,045% from $10.8M.
Arbitration process added $169.7M more revenue in 2024 than 2023; drove 73.1% of revenue growth.
Q4 2024 revenue $257.6M (+270% YoY); operating income $114.2M vs operating loss $26.1M.
Cash from ops $23.2M; total assets $655.3M; long-term debt $22.5M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.